Skip to content

AMD-OSDI Terapia iniettiva

Composizione del gruppo

Coordinatore:

  • Sandro Gentile (Napoli) – Email


Componenti AMD:

  • Stefano De Riu (Nocera Inferiore, SA)
  • Nicoletta De Rosa (Casoria, NA)
  • Giorgio Grassi (Torino)
  • Gabriella Garrapa (Fano, PU)
  • Laura Tonutti (Udine)


Componenti OSDI:

  • Katja Speese (Rovereto, TN)
  • Lia Cucco (Pescara)
  • Maria Teresa Branca (Lecce)


Referente CDN:

  • Amodio Botta (Avellino)

Componenti biennio 2013-2015


Coordinatore:
 Sandro Gentile (Napoli)
Componenti: 
Nicoletta De Rosa, Giorgio Grassi, Carlo Lalli, Maria Teresa Marcone, Maurizio Sudano
Consulenti esterni: 
Luigi Gentile, Annalisa Giancaterini, Patrizio Tatti, Laura Tonutti
Componenti OSDI: 
Lia Cucco, Giovanni Lo Grasso
Referente CDN: 
Vincenzo Armentano


Attività del gruppo

Raccomandazioni e survey

Documento di Consenso sul Recepimento Italiano del Forum for Injection Technique and Therapy Expert Recommendations (FITTER) 2015 – con aggiornamenti e integrazioni 2017 – scarica il pdf qui
Aggiornamento e integrazioni a cura del gruppo intersocietario AMD-OSDI sulle Tecniche iniettive – 16/05/2017

AMD-OSDI-SID – Raccomandazioni per una corretta tecnica iniettiva e per la prevenzione delle lipodistrofie e del rischio di punture accidentali (2015)
A cura un tavolo di lavoro di esperti AMD-OSDI-SID

Consensus 2014 AMD-OSDI sulle tecniche iniettive nel soggetto diabetico – scarica il pdf qui.

Survey sulle lipodistrofie 2014
Scarica il report finale della survey sulle lipodistrofie (dati al 10/09/2014) condotta del gruppo: clicca qui.


Presentazioni

VI Convegno nazionale Fondazione AMD
Baveno, 23-25 ottobre 2014

XIX Congresso nazionale AMD
Roma, 29 maggio – 1 giugno 2013


Pubblicazioni

Collana editoriale AMD
Articoli
  • Gentile S, Fusco A, Colarusso S, Piscopo M, Improta MR, Corigliano M, Martedi E, Oliva D, Santorelli A, Simonetti R, Giammarco A, Colella C, Miretto L, D’Alessandro A, Russo V, Guarino G, Marino G, Corigliano G, Strollo F. A randomized, open-label, comparative, crossover trial on preference, efficacy, and safety profiles of lispro insulin u-100 versus concentrated lispro insulin u-200 in patients with type 2 diabetes mellitus: a possible contribution to greater treatment adherence. Expert Opin Drug Saf. Published online 18 April 2018
  • Guarino G, Ragozzino G, Della Corte T, Fontana S, Strollo F, Cecaro M, and Gentile S. Selenium Supplementation in Obese Patients with Subclinical Hypothyroidism and Type 2 Diabetes. J Nutri Health Sci 2018;5(2):202
  • Gentile S, Fusco A, Colarusso S, Piscopo M, Improta MR, Corigliano M, Martedi E, Oliva D, Santorelli A, Simonetti R, Giammarco A, Colella C, Miretto L, D’Alessandro A, Russo V, Guarino G1, Marino G, Corigliano G, Strollo F. A randomized, open-label, comparative, crossover trial on preference, efficacy, and safety profiles of lispro insulin u-100 versus concentrated lispro insulin u-200 in patients with type 2 diabetes mellitus: a possible contribution to greater treatment adherence. Expert Opin Drug Saf 2018 Mar 22:1-6. [Epub ahead of print]
  • Gentile S, Strollo F, Della Corte T, Marino G, Guarino G, on behalf of Italian Study Group on Injection Techniques. Skin complications of insulin injections: A case presentation and a possible explanation of hypoglycaemia. Diabetes Res Clin Pract 2018;138:284-7
  • Fusco A, Colarusso S, Piscopo M, Improta MR, CoriglianoM, Martedi E, Oliva D, Santorelli A, Simonetti R, Giammarco A, Colella C, Miretto L, D’Alessandro A, Russo V, Guarino G, Marino G, Strollo F, Corigliano G, Gentile S. Despite being Apparently Equal, Concentrated Lispro-200 Performs Metabolically and Subjectively Better than Lispro-100. Divers Equal Health Care 2018;15(2):57-65
  • Gentile S, Strollo F, De Rosa N, Grassi G , Lalli C, Lo Grasso G, Marcone TAM, Sudano M, Gentile L, Giancaterini A, Tatti P, Tonutti L, De Riu S, Cucco L, Speese K, Botta A, Armentano V, Chiandetti R, Garrapa G. Injection-Related Local Side Effects in the Treatment of Diabe­tes Mellitus: A Methodological Approach and Possible Solutions. Consensus Statement of AMD-OSDI Study Group on Injection Technique Diabetic Complications. Diabetes Ther 2016;7(3):401-9
  • Gentile S, Strollo F. Subcutaneus nodules during treatment with exenatide long-actin once-weekly formulation: an ultrasound evaluation. Divers Equal Health Care 2016;13(4):313-318
  • Gentile S, Grassi G, Armentano V, Botta A, Cucco L, De Riu S, De Rosa N, Garrapa G, Gentile L, Giancaterini A, Lalli C, Lo Grasso G, Marcone TAM, Chiandetti R, Speese K, Sudano M, Tatti P, Tonutti L, Branca MT and Strollo F. AMD-OSDI Consensus on Injection Techniques for People with Diabetes Mellitus. Med Clin Rev. 2016, 2:3 doi: 10.21767/2471-299X.1000034
  • Frid AH, Kreugel G, Grassi G, Halimi S, Hicks D, Hirsch LJ, Smith MJ, Wellhoener R, Bode BW, Hirsch IB, Kalra S, Ji L, Strauss KW. New Insulin Delivery Recommendations. Mayo Clin Proc. 2016;91(9):1231-1255
  • Strollo F, Guarino G, Armentano V, Clemente G, Martedì E, De Riu S, Gaeta I, Corigliano G, Ceriello A, Gentile S; on behalf of AMD-OSDI Italian Study Group on Injection Techniques. Unexplained hypoglycaemia and large glycaemic variability: skin lipohypertrophy as a predictive sign. Diabetes Res Open J 2016; 2(1):24-32
  • Gentile S, Strollo F, Ceriello A, on behalf of the AMD-OSDI Injection Technique Study Group. Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear? Diabetes Ther 2016. doi:10.1007/s13300-016-0187-6
  • Gentile S, Guarino G, Giancaterini A, Guida P, Strollo F, and AMD-OSDI Italian Injection Technique Study Group. Suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin treated people with diabetes. Springerplus 2016;5:563
  • Gentile S, Strollo F, Ceriello A, on behalf of the AMD-OSDI Injection Technique Study Group. Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear? Diabetes Therapy 2016 (first online):1-9
  • Guarino G, Della Corte T, Sofia M, Carbone L, Marino G, Martedì E, Gentile S. Metabolic effects of the association Berberis aristata/Silybum marianum: a preliminary double-blind, placebo-controlled study in obese patients with type 2 diabetes. Nutrafoods 2015;14(4):181-188

Archivio